Venglustat in GBA1-related Parkinson's disease - Authors' reply

Lancet Neurol. 2024 Feb;23(2):137-138. doi: 10.1016/S1474-4422(23)00470-2.

Authors

S Pablo Sardi¹; MOVES-PD authors

Collaborators

MOVES-PD authors:
Nir Giladi, Roy N Alcalay, Gary Cuer, Thomas Gasser, Tanya Gurevich, Günter U Höglinger, Kenneth Marek, Claudio PaccheE, Anthony H V Schapira, Clemens R Scherzer, Tanya Simuni, Pascal Minini, M Judith Peterschmi

Affiliation

¹ Rare and Neurologic Diseases Research, Sanofi, Cambridge, MA 02141, USA. Electronic address: [email protected].

PMID: 38267178
DOI: 10.1016/S1474-4422(23)00470-2

No abstract available

Publication types

Letter
Comment

MeSH terms

Carbamates*
Humans
Parkinson Disease* / drug therapy
Parkinson Disease* / genetics
Quinuclidines*

Substances

venglustat
Carbamates
Quinuclidines